A phase II exploratory open-label study of recombinant human C1 inhibitor for the treatment of acute attacks of hereditary angioedema

被引：0
|
作者：
Choi, G
Soeters, M
Verdonk, R
van Dam, T
Nuijens, J
Hack, CE
Levi, M
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Pharming Grp NV, Leiden, Netherlands
[3] Sanquin Res, Dept Immunopathol, Asmera, Eritrea
来源：
MOLECULAR IMMUNOLOGY | 2004年 / 41卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
40
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR FOR ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA: AN OPEN-LABEL STUDY
    Li, H.
    Moldovan, D.
    Bernstein, J.
    Reshef, A.
    Porebski, G.
    Stobiecki, M.
    Baker, J.
    Levy, R.
    Hardiman, Y.
    Relan, A.
    Cicardi, M.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A92 - A93
  • [2] Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial
    Riedl, Marc A.
    Hurewitz, David S.
    Levy, Robyn
    Busse, Paula J.
    Fitts, David
    Kalfus, Ira
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (01) : 49 - 53
  • [3] Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study
    Riedl, Marc A.
    Levy, Robyn J.
    Suez, Daniel
    Lockey, Richard F.
    Baker, James W.
    Relan, Anurag
    Zuraw, Bruce L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 110 (04) : 295 - 299
  • [4] Open-label use of nanofiltered C1 esterase inhibitor (human) for the treatment of hereditary angioedema attacks
    Riedl, M.
    Zuraw, B.
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Busse, P.
    Bielory, L.
    Grant, A.
    Tillotson, G.
    Kalfus, I
    ALLERGY, 2011, 66 : 422 - 423
  • [5] Open-label use of nanofiltered C1 esterase inhibitor (human) for treatment of acute attacks of hereditary angioedema in pediatric subjects
    Lumry, W.
    Davis-Lorton, M.
    Manning, M.
    Craig, T.
    Tillotson, G.
    Kalfus, I
    Baker, J.
    ALLERGY, 2011, 66 : 418 - 418
  • [6] Recombinant C1 inhibitor for Acute Attacks of Hereditary Angioedema
    Reshef, A.
    Leibovich, I
    ALLERGY, 2009, 64 : 571 - 571
  • [7] Open-label use of nanofiltered C1 esterase inhibitor (human) for the prophylaxis of hereditary angioedema attacks
    Riedl, M.
    Zuraw, B.
    Baker, J.
    Hurewitz, D.
    White, M.
    Vegh, A.
    Bielory, L.
    Lumry, W.
    Davis-Lorton, M.
    Levy, R.
    Grant, A.
    Busse, P.
    Banerji, A.
    Li, H.
    Tillotson, G.
    Kalfus, I
    Broom, C.
    ALLERGY, 2011, 66 : 420 - 421
  • [8] Open-label use of nanofiltered C1 esterase inhibitor (human) for treatment or prophylaxis of acute attacks of hereditary angioedema in pregnant subjects
    Craig, T.
    Riedl, M.
    Riedl, M.
    Baker, J.
    Banerji, A.
    Hurewitz, D.
    Kalfus, I
    Tillotson, G.
    ALLERGY, 2011, 66 : 419 - 419
  • [9] Recombinant human C1 esterase inhibitor for the acute treatment of hereditary angioedema attacks in children
    Reshef, A.
    Grivcheva-Panovska, V
    Kessel, A.
    Kivity, S.
    Klimaszewska-Rembiasz, M.
    Moldovan, D.
    Farkas, H.
    Gutova, V
    Fritz, S.
    Bellizzi, L.
    Relan, A.
    Giannetti, B.
    Magerl, M.
    ALLERGY, 2018, 73 : 66 - 66
  • [10] Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study
    Moldovan, D.
    Reshef, A.
    Fabiani, J.
    Kivity, S.
    Toubi, E.
    Shlesinger, M.
    Triggiani, M.
    Montinaro, V.
    Cillari, E.
    Realdi, G.
    Cancian, M.
    Visscher, S.
    Zanichelli, A.
    Relan, A.
    Cicardi, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (06): : 929 - 935
12345